# Herunsheng Pharmaceutical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/herunsheng-pharmaceutical

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Latest round: Angel (Dec 22, 2025)
- Investors on record: 1

## About

Based in Hangzhou, China, and founded in 2025, Hangzhou Herunsheng Pharmaceutical Technology Co., Ltd., trading as Herunsheng Pharmaceutical, is a biotechnology service provider focusing on biotechnology services and research and development of nuclear medicine-related technologies. In December 2025, Herunsheng Pharmaceutical raised a series A funding from new investor Houxue Capital.
The company provides nuclear medicine technology services, cell technology solutions, and related equipment and consumables to biopharmaceutical companies and research institutions, focusing on the intersection of nuclear medicine and biotechnology.
The company’s revenue is generated by providing biopharmaceutical products and nuclear medicine-related technologies.
This series A round of financing will be used to advance its technological research and platform development in the biopharmaceutical field.

## Funding rounds

- Angel, Dec 22, 2025 — Houxue Capital

## Investors

- Houxue Capital (https://capitalatlas.ai/funds/houxue-capital) — Angel